Filing Details

Accession Number:
0000950170-24-084761
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-19 08:29:42
Reporting Period:
2024-07-17
Accepted Time:
2024-07-19 08:29:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841387 Candel Therapeutics Inc. CADL Biological Products, (No Disgnostic Substances) (2836) 522214851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873905 Peter Paul Tak C/O Candel Therapeutics, Inc.
117 Kendrick St., Suite 450
Needham MA 02494
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-17 22,528 $6.47 330,735 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units pursuant to the Issuer's mandatory sell to cover policy, which requires sales in an amount sufficient to cover tax withholding obligations associated with the vesting events, and the sales do not represent discretionary sales by the Reporting Person.